News & Press | Fabric Genomics

News & Press

The DNA of a Nation: Nature Magazine Highlights Omicia and the Necessity for Large-Scale Clinical Interpretation for 100,000 Genomes Project

In the recent article “The DNA of a Nation,” Nature magazine highlights the highly-specialized and dedicated clinical interpretation services that Genomics England requires for their 100,000 Genomes Project, which is the first step in bringing genomics to the UK healthcare system. Omicia, the worldwide leader in genome informatics and clinical

Read More »

Omicia Raises $23 Million in Series B Funding

Omicia, Inc., a leading provider of clinical genome interpretation and reporting software, today announced the completion of a $23 million Series B financing round. Several new investors participated in the round, including UPMC Enterprises, Roche Venture Fund, LDV Partners, Ping An Ventures, and a large genomics investor, as well as

Read More »

Omicia Implements ACMG Variant Scoring and Classification Guidelines to Drive Clinical NGS Report Consistency and Throughput

Omicia announces the launch of its new ACMG-scoring module for the Opal Clinical™ interpretation and reporting software platform at the 2016 ACMG Annual Clinical Genetics Meeting. This functionality provides an intuitive interface and workflow for clinical testing labs to systematically assess the disease-causing potential of genetic variants using the evidence-based

Read More »

Nature: The DNA of a Nation

The United Kingdom aims to sequence 100,000 human genomes by 2017. But screening them for disease-causing variants will require innovative software. For the 100,000 Genomes Project, it will use Omicia’s Opal Clinical genome interpretation software to assess which variants are likely to be causing disease.  

Read More »

Rare Genomics Institute BeHEARD Rare Disease Science Challenge Winners to Use Omicia’s Clinical NGS Interpretation Software

Rare Genomics Institute (RG) is an international non-profit that that makes cutting edge research technologies of genome sequencing, physicians and scientists around the world accessible to rare disease patients. In partnership with RG, Omicia is delighted to announce the recipients of this year’s BeHEARD Rare Disease Science Challenge, who will

Read More »